| 1.985 -0.045 (-2.22%) | 10-28 14:40 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.12 | 1-year : | 3.63 |
| Resists | First : | 2.67 | Second : | 3.1 |
| Pivot price | 2.46 |
|||
| Supports | First : | 1.97 | Second : | 1.63 |
| MAs | MA(5) : | 2.03 |
MA(20) : | 2.59 |
| MA(100) : | 2.81 |
MA(250) : | 3.35 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 5.8 |
D(3) : | 6.8  |
| RSI | RSI(14): 25 |
|||
| 52-week | High : | 17.2 | Low : | 1.86 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AIFF ] has closed above bottom band by 16.1%. Bollinger Bands are 198.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.11 - 2.12 | 2.12 - 2.14 |
| Low: | 1.97 - 1.99 | 1.99 - 2 |
| Close: | 2.01 - 2.03 | 2.03 - 2.05 |
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Wed, 22 Oct 2025
Windsor Private Capital sells Firefly Neuroscience (AIFF) shares for $290k - Investing.com Nigeria
Wed, 22 Oct 2025
Windsor Private Capital sells Firefly Neuroscience (AIFF) shares for $290k - Investing.com
Tue, 14 Oct 2025
Windsor private capital sells Firefly Neurosciences (AIFF) shares for $456k - Investing.com
Thu, 09 Oct 2025
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF) - PR Newswire
Fri, 05 Sep 2025
2,500 Mental Health Clinics Gain Access to FDA-Cleared AI Brain Analytics Through Firefly-HealingMaps Deal - Stock Titan
Tue, 26 Aug 2025
80% Processing Speed Boost: Firefly Neuroscience Revolutionizes Brain Data Analysis with NVIDIA-Powered Platform - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 1.167e+007 (%) |
| Held by Institutions | 32.2 (%) |
| Shares Short | 1,410 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.045e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -529.8 % |
| Return on Assets (ttm) | -81.2 % |
| Return on Equity (ttm) | -419.7 % |
| Qtrly Rev. Growth | 2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -2.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 491270 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|